NDC 10135-658 Quetiapine Extended Release
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
Product Characteristics
YELLOW (C48330)
YELLOW (C48330 - PALE YELLOW)
19 MM
382
383
Code Structure Chart
Product Details
What is NDC 10135-658?
What are the uses for Quetiapine Extended Release?
Which are Quetiapine Extended Release UNII Codes?
The UNII codes for the active ingredients in this product are:
- QUETIAPINE FUMARATE (UNII: 2S3PL1B6UJ)
- QUETIAPINE (UNII: BGL0JSY5SI) (Active Moiety)
Which are Quetiapine Extended Release Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
What is the NDC to RxNorm Crosswalk for Quetiapine Extended Release?
- RxCUI: 721791 - QUEtiapine fumarate 200 MG 24HR Extended Release Oral Tablet
- RxCUI: 721791 - 24 HR quetiapine 200 MG Extended Release Oral Tablet
- RxCUI: 721791 - quetiapine 200 MG (as quetiapine fumarate 230 MG) 24 HR Extended Release Oral Tablet
- RxCUI: 721791 - quetiapine 200 MG 24 HR Extended Release Oral Tablet
- RxCUI: 721794 - QUEtiapine fumarate 300 MG 24HR Extended Release Oral Tablet
* Please review the disclaimer below.
Patient Education
Quetiapine
Quetiapine tablets and extended-release (long-acting) tablets are used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Quetiapine tablets and extended-release tablets are also used alone or with other medications to treat episodes of mania (frenzied, abnormally excited or irritated mood) or depression in patients with bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). In addition, quetiapine tablets and extended-release tablets are used with other medications to prevent episodes of mania or depression in patients with bipolar disorder. Quetiapine extended-release tablets are also used along with other medications to treat depression. Quetiapine tablets may be used as part of a treatment program to treat bipolar disorder and schizophrenia in children and teenagers. Quetiapine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".